注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Aadi Bioscience Inc是一家商业阶段的生物制药公司,该公司致力于开发基因定义癌症的精准疗法。该公司的主要重点是为具有雷帕霉素机制靶点(mTOR)通路驱动改变的癌症患者开发治疗方法,例如TSC1或TSC2基因改变。该公司最初的重点是治疗一种超罕见的癌症血管周围上皮样细胞瘤(PEComa)。该公司的主导产品FYARROTM是一种与人白蛋白结合的mTOR抑制剂,在临床前模型中与其他mTOR抑制剂相比,具有肿瘤积累、mTOR靶点抑制和肿瘤生长抑制作用。FYARRO是一种mTOR抑制剂,适用于治疗患有晚期不可切除或转移性血管周围上皮样细胞瘤(PEComa)的成年患者。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Pravin U. Dugel | 57 | 2017 | Independent Director |
Michael T. Lotze | 69 | - | Member of Scientific Advisory Board |
Steven Prelack | 64 | 2017 | Independent Chairman |
Peter A. Campochiaro | - | - | Member of Scientific Advisory Board & Ophthalmology Advisory Board |
Christopher D. Kontos | - | - | Member of Scientific Advisory Board |
Dietmar Vestweber | - | - | Member of Scientific Advisory Board |
Anupam Dalal | 49 | 2011 | Independent Director |
Caley M. Castelein | 50 | 2017 | Independent Director |
Cheryl L. Cohen | 55 | 2018 | Independent Director |
David S. Boyer | - | - | Member of Ophthalmology Advisory Board |
Samir M. Parikh | - | - | Member of Scientific Advisory Board |
Peter K. Kaiser | - | - | Member of Ophthalmology Advisory Board |
Joseph H. Gardner | 65 | 2011 | Founder, President, Principal Executive Officer & Director |
Jeffrey S. Heier | 60 | - | Member of Ophthalmology Advisory Board |
W. Daniel Stamer | - | - | Member of Scientific Advisory Board |
Emma Reeve | 63 | 2021 | Independent Director |
Mohammad Hirmand | 54 | 2023 | Independent Director |
Anupam Dalal | 52 | 2021 | Independent Director |
Neil P. Desai | 59 | 2011 | Founder, Secretary & Executive Chairman |
David J. Lennon | 53 | 2023 | President, CEO & Director |
Caley M. Castelein | 53 | 2021 | Independent Director |
Richard Maroun | 69 | 2017 | Independent Director |
Behzad Aghazadeh | 53 | 2021 | Independent Director |
Karin M. Hehenberger | 52 | 2021 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核